Rare female genital cancers

SCIENTIFIC COORDINATORS: Isabelle Ray-Coquard, FR and Michael Seckl, UK
                                    
The online course on rare female genital cancers is addressed to an international audience of clinical oncologists interested in advancing their knowledge and skills on the clinical management of these tumors in a multidisciplinary context.
Taking into account that “networking” is the keyword  to improve quality of care of rare cancers, the course is developed in the framework of EURACAN, the European Reference Network on rare adult solid cancers, with the aim of reinforcing  the collaboration among oncologists of different countries who are already part of the network or willing to be part of it in the near future.

FORMAT
The course is made up of a series of pre-recorded lectures (available online from 1 December 2021).


LEARNING OBJECTIVES
 

- To provide an overview of current multidisciplinary state-of-the-art treatment of rare female genital cancers

- To establish connections for future distance clinical mentoring/tutoring/networking

 

PARTICIPANT'S PROFILE

• Medical degree

• Current involvement in clinical activities in oncology

• Fluency in English


OFFICIAL LANGUAGE

The official language will be English. No translation will be provided.


CME ACCREDITATION CERTIFICATES

Participants will be issued a certificate of attendance (minimum attendance: 75% of the entire course). An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certficate that will be issued by email. 
Application for CME recognition has been submitted to the Accreditation Council of Oncology in Europe (ACOE) and 4 CME credits have been granted to this event.
The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.
CME credits will be available until 1 December 2023.
 

  ESCO CREDITS

The course enables ESCO students to earn ESCO credits and therefore access more ESCO benefits. Full and active participation in the Course earns participants 4 ESCO credits.

Visit www.esco.org for information on how to join ESCO.


REGISTRATION

Registration for the course is required but free (you can find the registration link on the right).

Registration will be confirmed by e-mail.


ORGANISING SECRETARIAT

Marina Fregonese
email: mfregonese@eso.net

SOCIAL MEDIA

Use the hashtag #ESOexperience and follow us on Facebook, Twitter and Instagram: @esoncology


Instructions on how to use e-ESO to participate in this event

Germ cell tumours

01/12/2021

Expert: Domenica Lorusso, IT

Sex cord stromal tumours: Granulosa cell tumours/juvenile versus adult; Sertoli-Leydig cell tumours

01/12/2021

Expert: Isabelle Ray-Coquard, FR

Low grade serous tumours

01/12/2021

Expert: Jalid Sehouli, DE

Low and high risk gestational trophoblastic neoplasia

01/12/2021

Expert: Michael Seckl, UK

Atypical placental site nodule, placental site trophoblastic tumour, epithelioid trophoblastic tumour

01/12/2021

Expert: Christianne Lok, NL

Non squamous carcinoma: vulvar and vaginal

01/12/2021

Expert: Christoph Grimm, AT

Ovarian and uterine carcinosarcomas

01/12/2021

Expert: Frédéric Amant, BE

Small cell cancers: cervix versus ovary

01/12/2021

Expert: Alice Bergamini, IT
Frédéric Amant

UZ Leuven, Leuven, Belgium

Alice Bergamini

Ospedale San Raffaele, Milan, Italy

Christoph Grimm

Medical University, Vienna, Austria

Christianne Lok

Netherlands Cancer Institute, Amsterdam, The Netherlands

Domenica Lorusso

Gynaecological Oncology Unit, Humanitas San Pio X; Humanitas University, Milan, Italy

Isabelle Ray-Coquard

Léon Bérard Center, Lyon, France

Michael Seckl

Hammersmith Campus, London, United Kingdom

Jalid Sehouli

Charité Universitätsmedizin Berlin, Berlin, Germany